Inari Medical, Inc. reaffirmed revenue guidance for the full year 2022. For the year, company reaffirming revenue guidance range of $360 million to $370 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 USD | +1.61% |
|
-1.54% | -28.90% |
Jun. 20 | Inari Medical Insider Sold Shares Worth $1,741,579, According to a Recent SEC Filing | MT |
May. 23 | Sector Update: Health Care Stocks Lower Thursday Afternoon | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.90% | 2.64B | |
+75.69% | 12.57B | |
+11.24% | 7.21B | |
-30.25% | 6.82B | |
+11.54% | 5.35B | |
-20.60% | 4.59B | |
+10.66% | 3.95B | |
-21.44% | 3.69B | |
+28.43% | 2.09B | |
-1.36% | 2.03B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2022